Ads
related to: PfizerSCBN.org has been visited by 10K+ users in the past month
Search results
Is Pfizer Stock A Sell As Shares Hit A 9-Year Low Amid The Search For Its Next Big Break?
Investor's Business Daily· 1 day agoPfizer stock is trading at a nine-year low as the drugmaker looks for its next big break after...
Pfizer On The New Lows List. Big Dividend Fails To Attract Buyers.
Forbes· 21 hours agoYou might think that a big, well-known healthcare firm offering a 6.6% dividend would attract investors. The drug maker is a big one with a market capitalization of $143 billion and average ...
U.S. regulators give full approval to Pfizer COVID-19 vaccine
AOL· 4 hours agoThe U.S. gave full approval to Pfizer's COVID-19 vaccine on Monday, a milestone that may help lift public confidence in the shots as the nation battles the most contagious ...
Here is What to Know Beyond Why Pfizer Inc. (PFE) is a Trending Stock
Zacks via Yahoo Finance· 13 hours agoPfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good...
Fact Check: mRNA Jabs Have Allegedly Caused a '14,000% Increase in Turbo Cancer.' Here's What We...
Snopes via Yahoo News· 2 hours agoRating: Myriad publications have falsely warned readers about "turbo cancer," a purportedly...
Pfizer accused of ‘bringing discredit’ on pharmaceutical industry after Covid social media posts
The Telegraph via Yahoo News· 2 weeks agoPfizer has been accused by the UK’s pharmaceutical watchdog of “bringing discredit” on the industry...
Where Will Pfizer Stock Be in 10 Years?
Motley Fool via Yahoo Finance· 1 week agoPfizer (NYSE: PFE) stock has been struggling for a while now. In the past 12 months, it has declined by 36%. A lack of growth recently, a dependence on...
Boston Trust Walden Corp Lowers Holdings in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 weeks agoBoston Trust Walden Corp trimmed its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 4.5% during the 4th quarter, according to its most recent Form 13F filing with the ...
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
CNBC· 2 weeks agoA vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk...
Blue Bell Private Wealth Management LLC Has $348,000 Position in Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 2 weeks agoBlue Bell Private Wealth Management LLC lessened its holdings in Pfizer Inc. (NYSE:PFE – Free Report) by 13.3% during the fourth quarter, according to the company in its most ...